Ameriprise’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.35M | Sell |
135,073
-7,188
| -5% | -$266K | ﹤0.01% | 2528 |
|
|
2025
Q4 | $5.99M | Sell |
142,261
-9,420
| -6% | -$380K | ﹤0.01% | 2308 |
|
|
2025
Q3 | $5.21M | Buy |
+151,681
| New | +$4.35M | ﹤0.01% | 2419 |
|
|
2025
Q2 | – | Sell |
-75,071
| Closed | -$2.23M | – | 4137 |
|
|
2025
Q1 | $2.23M | Sell |
75,071
-15,319
| -17% | -$584K | ﹤0.01% | 2837 |
|
|
2024
Q4 | $3.58M | Sell |
90,390
-64
| -0.1% | -$2.42K | ﹤0.01% | 2595 |
|
|
2024
Q3 | $3.08M | Buy |
+90,454
| New | +$2.54M | ﹤0.01% | 2692 |
|
|
2024
Q1 | – | Sell |
-22,179
| Closed | -$610K | – | 3961 |
|
|
2023
Q4 | $610K | Sell |
22,179
-146,910
| -87% | -$3.55M | ﹤0.01% | 3370 |
|
|
2023
Q3 | $3.78M | Sell |
169,089
-5,010
| -3% | -$129K | ﹤0.01% | 2494 |
|
|
2023
Q2 | $4.43M | Buy |
174,099
+49,558
| +40% | +$1.2M | ﹤0.01% | 2437 |
|
|
2023
Q1 | $2.78M | Buy |
124,541
+3,963
| +3% | +$95.8K | ﹤0.01% | 2683 |
|
|
2022
Q4 | $2.86M | Sell |
120,578
-14,131
| -10% | -$328K | ﹤0.01% | 2641 |
|
|
2022
Q3 | $2.23M | Sell |
134,709
-35,919
| -21% | -$808K | ﹤0.01% | 2741 |
|
|
2022
Q2 | $3.4M | Sell |
170,628
-5,204
| -3% | -$105K | ﹤0.01% | 2542 |
|
|
2022
Q1 | $4.85M | Sell |
175,832
-24,098
| -12% | -$689K | ﹤0.01% | 2444 |
|
|
2021
Q4 | $8.24M | Buy |
199,930
+162,535
| +435% | +$7.18M | ﹤0.01% | 2123 |
|
|
2021
Q3 | $1.74M | Sell |
37,395
-10,041
| -21% | -$438K | ﹤0.01% | 2922 |
|
|
2021
Q2 | $1.9M | Buy |
47,436
+42,784
| +920% | +$1.83M | ﹤0.01% | 2952 |
|
|
2021
Q1 | $250K | Buy |
+4,652
| New | +$268K | ﹤0.01% | 3650 |
|
|
2020
Q3 | – | Sell |
-68,410
| Closed | -$1.77M | – | 3791 |
|
|
2020
Q2 | $1.77M | Buy |
68,410
+1,167
| +2% | +$29.1K | ﹤0.01% | 2671 |
|
|
2020
Q1 | $1.64M | Sell |
67,243
-8,823
| -12% | -$222K | ﹤0.01% | 2576 |
|
|
2019
Q4 | $2.12M | Buy |
76,066
+18,095
| +31% | +$468K | ﹤0.01% | 2707 |
|
|
2019
Q3 | $1.39M | Sell |
57,971
-14,265
| -20% | -$379K | ﹤0.01% | 2866 |
|
|
2019
Q2 | $2.06M | Buy |
+72,236
| New | +$1.8M | ﹤0.01% | 2744 |
|
|
2019
Q1 | – | Sell |
-94,980
| Closed | -$1.2M | – | 3770 |
|
|
2018
Q4 | $1.2M | Buy |
+94,980
| New | +$1.12M | ﹤0.01% | 2874 |
|
|
2014
Q4 | – | Sell |
-52,875
| Closed | -$516K | – | 4395 |
|
|
2014
Q3 | $516K | Sell |
52,875
-17,000
| -24% | -$223K | ﹤0.01% | 3037 |
|
|
2014
Q2 | $1.2M | Sell |
69,875
-1,840
| -3% | -$26.5K | ﹤0.01% | 2710 |
|
|
2014
Q1 | $1.23M | Buy |
71,715
+10,100
| +16% | +$161K | ﹤0.01% | 2652 |
|
|
2013
Q4 | $893K | Buy |
+61,615
| New | +$802K | ﹤0.01% | 2694 |
|
Other funds holding VCYT
VPM
VCM
AIM
Ameriprise's VCYT Position: Q1 2026 in Review
Ameriprise reduced its Veracyte (VCYT) stake by 5.1% in Q1 2026, selling an estimated $266K and leaving 135,073 shares worth $4.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2528.
Ameriprise first reported a position in VCYT in Q4 2013 and has held it in 28 quarters since. The position peaked at $8.24M in Q4 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Ameriprise held 135,073 shares of Veracyte worth $4.35M as of Q1 2026.
- Ameriprise sold 7,188 Veracyte shares in Q1 2026, an estimated $266K.
- Veracyte made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2528 holding.
- Ameriprise first reported a position in Veracyte in Q4 2013 and has held it in 28 quarters since.
- Ameriprise's Veracyte position peaked at $8.24M in Q4 2021.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.